STOCK
UTHR UNITED THERAPEUTICS
Held by 13 of 73 curated managers · 13 total holders in our 13F universe.
FUNDAMENTALS
Market Cap
$26.1B
P/E (Trailing)
19.38
P/E (Forward)
15.89
PEG Ratio
2.22
Price/Book
3.75
Profit Margin
40.6%
Gross Margin
86.6%
Revenue Growth YoY
-1.6%
Earnings Growth YoY
-12.2%
Dividend Yield
0.0%
52-Week Range
$272.12 – $609.35
Fundamentals: Yahoo Finance · Jul 30, 2026
QUARTERLY FINANCIALS
Revenue & Net Margin — UTHR
Source: Yahoo Finance (yfinance) · 5 quarters
SMART MONEY HOLDERS · from our curated set
Top managers holding UTHR
-
Renaissance Technologies LLC Quant. Different beast — opt in or out.1.7%
-
Sectoral Asset Management Inc. Concentrated bets. Extreme alpha generation.0.9%
-
Bridgewater Associates, LP Macro long-term framework.0.3%
-
WINTON GROUP Ltd Berkshire proxy with modest alpha generation.0.3%
-
Citadel Advisors LLC Citadel — systematic quantitative dominance.0.2%
-
Erste Asset Management GmbH Outsize alpha. Tech-heavy concentration. Sparse positioning.0.1%
-
Aigen Investment Management, LP Fifty percent alpha on fifty-two positions.0.1%
-
Citigroup Inc. Tech mega-cap concentration. Outperformance through concentration.0.1%
-
State Street Corp. Index tracker with mega-cap tech tilt.0.0%
-
Knightsbridge Asset Management, LLC Semiconductor concentration. Twenty-four percent alpha.0.0%
EDITORIAL BRIEF
The editorial brief for UTHR is being prepared. Stock briefs roll out across Q3 starting with the most-held names.
INSIDER TRADES · recent
- Benkowitz Michael Dec 29, 2025 SELL $7.35M
- Benkowitz Michael Feb 17, 2026 SELL $7.03M
- Benkowitz Michael Jan 12, 2026 SELL $7.01M
- Benkowitz Michael Dec 8, 2025 SELL $7.00M
- Benkowitz Michael Feb 9, 2026 SELL $6.94M
CONGRESS TRADES · recent
No STOCK Act trades on file for UTHR.